|
||||||||||||||||
|
||||||||||||||||
The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. APPENDICES
|
||||||||||||||||
|
| ||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 14
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices
APPENDICES
OCR for page 15
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices
TABLE 1. Annual Awards and Expenditures of Section 317 Direct Assistance (DA) Vaccine Purchase Funds (in millions)
Year
New Funds
Rewarded Fundsa
Total Award
Expenditures
Percentage of Total Award Expendedb
1990
$149.0
$0.0
$149.0
$106.3
71%
1991
$112.9
$37.5
$150.3
$102.5
68%
1992
$156.2
$26.8
$183.1
$121.6
66%
1993
$171.2
$43.9
$215.1
$156.0
73%
1994
$136.2
$86.3
$222.5
$172.4
78%
1995c
$85.3
$77.0
$162.3
$96.3
59%
1996
$133.3
$11.0
$144.2
$111.2
77%
1997
$124.0
$34.7
$158.7
$128.4
81%
1998d
$108.2
$34.9
$143.1
$135.6
95%
1999e
$128.0
$6.0
$134.0
aFunds awarded in previous years but not obligated.
bBased on year-end unobligated balances for 1990-1997 reported to CDC as of 4/1/99.
c$53 million rescinded from unobligated balances in FY96 (comprised of funds from 1993, 1994, and 1995).
dCDC estimates for expenditures and percentage of 1998 award expen ded.
eProjected amounts for 1999. NOTES: (a) CDC notes that 1990 was the first year that grants were administered centrally, instead of by regional offices. There is limited background information on which to substantiate these amounts and as a result their accuracy is questionable. (b) In 1994, an additional $30,672,686 in appropriated vaccine purchase funds was paid directly to the Treasury for floor stocks excise taxes on behalf of all the grantees when the Vaccine Compensation Act was reauthorized.
SOURCE: Data provided by CDC.
OCR for page 16
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices
TABLE 2. Annual Awards and Expenditures of Section 317 Financial Assistance (FA) Immunization Program Funds (in millions)
Year
New Funds
Rewarded Fundsa
Total Award
Expenditures
Percentage of Total Award Expendedb
1990
$36.9
$0.0
$36.9
$25.8
70%
1991
$37.0
$6.3
$43.3
$32.2
74%
1992
$92.3
$5.9
$98.2
$43.0
44%
1993
$98.2
$42.2
$140.4
$81.8
58%
1994
$227.6
$27.3
$254.9
$135.4
53%
1995
$261.4
$75.2
$336.6
$195.4
58%
1996
$179.7
$191.4
$371.1
$247.7
67%
1997
$159.4
$121.7
$281.1
$241.8
86%
1998c
$116.8
$77.8
$194.6
$186.1
96%
1999d
$117.0
$13.0
$130.0
$130.0
100%
aFunds awarded in previous years but not obligated.
bBased on year-end unobligated balances for 1990-1997 reported to CDC as of 12/21/98.
cCDC estimates for 1998 expenditures and percentage of 1998 award expended.
dProjected amounts for 1999.
SOURCE: Data Provided by CDC.
OCR for page 17
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices
Figure 1. Amount of New Funding Awarded as Section 317 Direct Assistance (DA) and Financial Assistance (FA), 1990-1999
Figure 2. Amount of Total Annual Awards of Section 317 Funds, Direct Assistance (DA) and Financial Assistance (FA), 1990-1999
OCR for page 18
Preliminary Considerations Regarding Federal Investments in Vaccine Purchase and Immunization Services: Interim Report on Immunization Finance Policies and Practices
Figure 3. Section 317 Grant Allocations from CDC to State and Local Immunization Programs, 1988-1999
Representative terms from entire chapter:
vaccine purchase
